About Us

LifeScience (Genomics) Researchborder
Click for the Website


Neo Science Equipment’s & Chemicals Trading L.L.C. with Neo Science and Group partners with Future Care Alliance FZE, to introduce whole genome sequencing and interpretation to consumers and their physicians in the Middle East

Bruno Rosset, Founder and CEO of Future Care Alliance: "We are proud and delighted to partner with Neo Science who is relentlessly pushing the boundaries of science and technology, to empower people to live healthier, longer"

In June 2017Future Care Alliance entered into a collaboration agreement with Veritas Genetics, Harvard Medical School and Professor George Church. Professor Church set in motion countless genetic discoveries, including the Human Genome Project, the first initiative to map all the human genome. George along with a Group of visionaries and scientists, also initiated the Personal Genome Project at Harvard Medical School.



Click for the Website

Click for the Website

 

The MerMade family of DNA / RNA synthesizers have been used to synthesize millions of high quality oligonucleotides across a broad range of applications. Our oligonucleotide synthesizers are flexible enough to fit a wide variety of DNA synthesis and RNA synthesis applications including gene synthesis, PCR, RNAi, dual labeled probes, microarrays, sequencing, and antisense experiments. Whether your DNA or RNA synthesizer requirements are a few custom oligos a week or several thousand a day we have a MerMade that will fit your needs.


Click for the Website

Click for the Website

 

BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support.





Click for the Website

Click for the Website

 

Flow Cytometers without Compromise

Stratedigm was founded in 2004 with the mission to create flow cytometry products that break from convention. We believe that having to choose between compact yet low-end, or bulky yet high-end flow cytometers is an artifact of compromised design. Since 2008, Stratedigm has launched a comprehensive product line of flow cytometry platforms, all driven by the same intuitive software, enabling easy standardization across all of our products. Based on a foundation of patented, future-proof platforms with industry-leading performance, our product suite offers seamless upgradeability across our S1000 flow cytometers. With the industry’s most advanced high throughput plate loader and hotel, the S1000 family of flow cytometers go head-to-head with BD FACS Canto, BD LSR, and BD Fortessa flow cytometers at a fraction of the cost and size while offering a superior solution for conventional and high throughput flow cytometry applications. This is the power of cytometry without compromise. The vision and execution of six generations of the most advanced flow cytometers on the market today. “Cytometry without compromise” is not merely our mission statement, it is our passion; it is our decade long legacy.



Click for the Website

Click for the Website

 

BGI was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research, which has generated over 2,137 publications, many in top-tier journals such as Nature and Science.

BGI is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI also has offices and laboratories located in Europe, North America and the Asia Pacific region. BGI currently operates in more than 100 countries and regions and works with more than 3000 medical institutions and more than 300 hospitals.



-->
LifeScience Diagnosticsborder
Click for the Website

Click for the Website

 

Analytical AB, a company founded in 1990 with headquarters in Padua, in the Northeast Italian. We specialize in the development and sale of diagnostic systems for the professional user. Highly qualified researchers and the constant collaboration with research centers University Hospital and helped to consolidate in the years scientific knowledge and expertise to the development of diagnostic systems up to date with the most recent guidelines of the sector, with the aim of associating quality, innovation and safety.



Click for the Website

Click for the Website

 

PathoFinder is a privately owned molecular diagnostics company founded in 2004. The company focuses on the development and commercialization of a new generation of molecular diagnostics, with special emphasis on infectious diseases. Our proprietary MultiFinder® and SmartFinder® technologies allows for the detection and differentiation of up to 22 viral and bacterial pathogens in a single assay. PathoFinder is based in Maastricht, The Netherlands.


Click for the Website

Click for the Website

 

ZEUS SCIENTIFIC CREATES INNOVATIVE, HIGH QUALITY, AND COST-EFFECTIVE DIAGNOSTIC SOLUTIONS THAT ENHANCE PATIENT CARE

ZEUS Scientific is a global leader in the field of clinical diagnostics products. The company has a developing pipeline of innovative, high quality, and cost-effective diagnostic solutions geared toward the enhancement of patient care. ZEUS Scientific products are marketed and distributed worldwide through a network of quality distribution partnerships. For over 35 years ZEUS Scientific has been a pioneer in immunofluorescence assays (IFA). The updated ZEUS IFA product line features liquid ready to use components in virtually every test system, multiple diluent options including, a unique color changing diluent and a broad menu of assays across both autoimmune disease and infectious serology testing. In addition, ZEUS IFA test systems are prepared by following a strict, proprietary cell fixation process which allows laboratories to work with cells that contain natural, unaltered antigens that can be easily observed through the lens of a microscope.




Click for the Website

 

Dirui Industrial Co., Ltd., established in Changchun, China in 1992, is a listed company on the GEM market of the Shenzhen Stock Exchange. The company's focus is on becoming a global service provider of laboratory total solutions through the research, development, production, marketing, and service of in-vitro diagnostic devices and reagents.





Click for the Website

Takara Bio USA, Inc. (TBUSA, formerly known as Clontech Laboratories, Inc.) provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, TBUSA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology.